Novartis invested 204 million EUR in Slovenia in 2020

0
3
Novartis Lek. (Photo: Tamino Petelinsek/STA)

By: H.L., STA

The Swiss pharma giant Novartis continued to invest in its R&D and production capacities in Slovenia through its subsidiaries Lek, Sandoz and Novartis Pharma Services last year.

Despite the Covid-19 pandemic, the company said it had invested EUR 204 million in the country as part of its efforts to expand its R&D and production facilities in line with its plan to transform from a generics to an innovative pharmaceutical company.

Share